| Financial Year |
March 31 2023 |
| Monetary Funds |
322,697,509.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
153,696,266.41 |
| Accounts Receivable |
457,803,073.28 |
| Advances to Suppliers |
131,269,367.46 |
| Other Receivables |
41,504,730.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,984,104,784.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,446,913.53 |
| Total Current Assets |
3,092,522,645.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,260,716.95 |
| Fixed Assetes |
82,824,451.73 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,298,927.39 |
| R&D expenses |
-- |
| Goodwill |
1,090,036,192.37 |
| Long-Term Deferred and Prepaid Expenses |
4,583,744.95 |
| Deferred Income Tax Assets |
21,821,810.30 |
| Other Non-Current Assets |
447,298.20 |
| Sub-Total of Non-Current Assets |
1,641,571,542.68 |
| Total Assets |
4,734,094,188.41 |
| Short-Term Loans |
488,066,478.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
18,198,000.00 |
| Accounts Payable |
385,343,916.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,822,107.81 |
| Taxes Payable |
86,086,702.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,786,140.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
100,570,791.23 |
| Other Current Liabilities |
73,910,422.02 |
| Sub-Total of Current Liabilities |
1,474,824,455.69 |
| Long-term Loans |
815,990,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
40,540,848.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
874,661,100.15 |
| Total Liabilities |
2,349,485,555.84 |
| Paid-In Capital(Or Share Stock) |
457,565,767.00 |
| Capital Surplus |
549,906,985.87 |
| Surplus Reserve |
82,457,190.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,194,946,111.09 |
| Minority Stockholder's Interest |
27,230,199.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,357,378,432.73 |
| Owner's Equity（Stockholder's Equity） |
2,384,608,632.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,734,094,188.41 |
